We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
64 hedge funds and large institutions have $133M invested in Verrica Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
127% more capital invested
Capital invested by funds: $58.5M → $133M (+$74.1M)
60% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 15
0.73% more ownership
Funds ownership: 3.58% → 4.31% (+0.73%)
4% less funds holding
Funds holding: 67 → 64 (-3)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
66% less call options, than puts
Call options by funds: $209K | Put options by funds: $620K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
24
Reduced
15
Closed
11
Calls
$209K
Puts
$620K
Net Calls
-$411K
Net Calls Change
-$294K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$8.47M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$4.3M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$444K |
| 4 |
Morgan Stanley
New York
|
+$426K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$351K |
Top Sellers
| 1 |
CP
Caligan Partners
New York
|
-$1.01M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$649K |
| 3 |
Renaissance Technologies
New York
|
-$265K |
| 4 |
Two Sigma Investments
New York
|
-$251K |
| 5 |
Millennium Management
New York
|
-$110K |
